Uwe Grether

This inventor holds 70 USPTO granted patents and 25 published patent applications, plus 4 CIPO patents and 34 EPO patents, primarily in Heterocyclic Compounds (CPC class C07D). Top assignees: Hoffmann-La Roche Inc., ETH Zurich, Unversität Zürich. Active years: 2003-2026.

USPTO Granted Patents = 70 (Patent Applications = 25)

% Patents Active = 32.9

CIPO Patents = 4 (Patent Applications = 11)

EPO Patents = 34 (Patent Applications = 40)

Average Co-Inventor Count = 7.1

ph-index = 6

Forward Citations = 179(Granted Patents)

Forward Citations (Not Self Cited) = 72(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Loerrach, DE (2003 - 2009)
Efringen-Kirchen, DE (2007 - 2023)
Basel, CH (2021 - 2023)

Company Filing History:

70 out of 5,020

Hoffmann-La Roche Inc.

where one patent can have more than one assignee

Years Active: 2003-2026

Loading Chart...

Areas of Expertise:

Heterocyclic Compounds

MAGL Inhibitors

Cannabinoid Receptor

Pyridine Derivatives

Pyrazine Derivatives

Triazolo Derivatives

Piperazine Derivatives

Phenyl Derivatives

Purine Derivatives

Pyrrolidine Derivatives

Benzimidazole Derivatives

Proline Derivatives

70 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12662490 - Heterocyclic compounds (2026-06-23),

2. 12637454 - Heterocyclic monoacylglycerol lipase (MAGL) inhibitors (2026-05-26),

3. 12281124 - Heterocyclic compounds as monoacylglycerol lipase inhibitors (2025-04-21),

4. 11814375 - Heterocyclic compounds (2023-11-14),

5. 11802133 - Heterocyclic compounds as monoacylglycerol lipase inhibitors (2023-10-31),

6. 11655243 - Pyridine and pyrazine derivatives as preferential cannabinoid 2 agonists (2023-05-23),

7. 11608347 - Octahydropyrido[1,2-alpha]pyrazines as MAGL inhibitors (2023-03-21),

8. 11420961 - Heterocyclic compounds (2022-08-23),

9. 11390610 - Piperazine derivatives as MAGL inhibitors (2022-07-19),

10. 11339120 - Phenyl derivatives as cannabinoid receptor 2 agonists (2022-05-24),

11. 11117903 - Pyridine derivatives (2021-09-14),

12. 10457686 - [1,2,3]triazolo[4,5-D]pyrimidine derivatives (2019-10-29),

13. 10457685 - [1,2,3]triazolo[4,5-D]pyrimidine derivatives with affinity for the type-2 cannabinoid receptor (2019-10-29),

14. 10457684 - [1,2,3]triazolo[4,5-d]pyrimidine derivatives (2019-10-29),

15. 10450321 - [1,2,3]triazolo[4,5-D]pyrimidine derivatives (2019-10-22),

Title: The Innovative Journey of Uwe Grether

Introduction: Uwe Grether, a visionary inventor hailing from Efringen-Kirchen, Germany, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents: Uwe Grether holds several patents in the field of renewable energy technologies, with his most recent patent focusing on a revolutionary solar panel design that increases energy efficiency by 30%.

Career Highlights: With over two decades of experience in the renewable energy sector, Uwe Grether has led research teams in developing cutting-edge solutions for sustainable energy production. His work has been recognized globally, earning him prestigious awards in the field.

Collaborations: Throughout his career, Uwe Grether has collaborated with leading research institutions and universities to further advance renewable energy technologies. His partnerships have resulted in successful projects that have shaped the future of clean energy.

Conclusion: Uwe Grether's passion for innovation and commitment to sustainability have positioned him as a key figure in the renewable energy industry. His relentless pursuit of technological advancements continues to inspire the next generation of inventors and researchers worldwide.